Repeated exposure of non-human primates to monoclonal antibody and fragments: pharmacokinetic studies and their implications for targeted therapy.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002143:Callitrichinae / Q000378:metabolism*; D007128:Immunoglobulin Fragments / Q000493:pharmacokinetics* / Q000627:therapeutic use; D009447:Neuroblastoma / Q000628:therapy
D000911:Antibodies, Monoclonal; D007128:Immunoglobulin Fragments